Neurodegenerative disease research in the 21st century.
Bales
Kelly R
KR
Neuroscience Discovery Research, Eli Lilly & Company, Indianapolis, IN 46285, USA. bales_kelly_r@lilly.com
D000818:Animals; D002144:Callithrix; D002478:Cells, Cultured; D017322:Clinical Trials, Phase II as Topic; D004195:Disease Models, Animal; D016503:Drug Delivery Systems / Q000379:methods; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005544:Forecasting; D020022:Genetic Predisposition to Disease; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D019636:Neurodegenerative Diseases / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy*; D040901:Proteomics